Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W BUTLER

Showing results (321-330 of 341) with videos related to

Pageof 35
Sort By:
ACS Medicinal Chemistry Letters|May 26, 2015
Design of Pyridopyrazine-1,6-dione γ-Secretase Modulators that Align Potency, MDR Efflux Ratio, and Metabolic StabilityMartin Pettersson, Douglas S Johnson, John M Humphrey, et al.
Cell Chemical Biology|September 30, 2020
Photoaffinity Labeling and Quantitative Chemical Proteomics Identify LXRβ as the Functional Target of Enhancers of Astrocytic apoEUthpala Seneviratne, Zhen Huang, Christopher W Am Ende, et al.
Medchemcomm|August 16, 2018
Discovery of cyclopropyl chromane-derived pyridopyrazine-1,6-dione γ-secretase modulators with robust central efficacyMartin Pettersson, Douglas S Johnson, Danica A Rankic, et al.
The American Journal of Psychiatry|April 3, 2010
Genome-wide pharmacogenetics of antidepressant response in the GENDEP projectRudolf Uher, Nader Perroud, Mandy Y M Ng, et al.
Journal of Affective Disorders|November 13, 2013
Investigating the genetic variation underlying episodicity in major depressive disorder: suggestive evidence for a bipolar contributionPanagiotis Ferentinos, Margarita Rivera, Marcus Ising, et al.
Plos One|July 14, 2011
Genomewide association scan of suicidal thoughts and behaviour in major depressionAlexandra Schosser, Amy W Butler, Marcus Ising, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 26, 2014
Genetic relationships between suicide attempts, suicidal ideation and major psychiatric disorders: a genome-wide association and polygenic scoring studyNiamh Mullins, Nader Perroud, Rudolf Uher, et al.
The American Journal of Psychiatry|May 17, 2011
A genome-wide significant linkage for severe depression on chromosome 3: the depression network studyGerome Breen, Bradley Todd Webb, Amy W Butler, et al.
Journal of Medicinal Chemistry|September 21, 2011
Discovery of two clinical histamine H(3) receptor antagonists: trans-N-ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidinylmethyl)phenyl]cyclobutanecarboxamide (PF-03654746) and trans-3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]-N-(2-methylpropyl)cyclobutanecarboxamide (PF-03654764)Travis T Wager, Betty A Pettersen, Anne W Schmidt, et al.
The American Journal of Psychiatry|June 3, 2010
Genome-wide association study of major recurrent depression in the U.K. populationCathryn M Lewis, Mandy Y Ng, Amy W Butler, et al.
Pageof 35

Showing results (321-330 of 341) with videos related to

Sort By:
Pageof 35
ACS Medicinal Chemistry Letters|May 26, 2015
Design of Pyridopyrazine-1,6-dione γ-Secretase Modulators that Align Potency, MDR Efflux Ratio, and Metabolic StabilityMartin Pettersson, Douglas S Johnson, John M Humphrey, et al.
Cell Chemical Biology|September 30, 2020
Photoaffinity Labeling and Quantitative Chemical Proteomics Identify LXRβ as the Functional Target of Enhancers of Astrocytic apoEUthpala Seneviratne, Zhen Huang, Christopher W Am Ende, et al.
Medchemcomm|August 16, 2018
Discovery of cyclopropyl chromane-derived pyridopyrazine-1,6-dione γ-secretase modulators with robust central efficacyMartin Pettersson, Douglas S Johnson, Danica A Rankic, et al.
The American Journal of Psychiatry|April 3, 2010
Genome-wide pharmacogenetics of antidepressant response in the GENDEP projectRudolf Uher, Nader Perroud, Mandy Y M Ng, et al.
Journal of Affective Disorders|November 13, 2013
Investigating the genetic variation underlying episodicity in major depressive disorder: suggestive evidence for a bipolar contributionPanagiotis Ferentinos, Margarita Rivera, Marcus Ising, et al.
Plos One|July 14, 2011
Genomewide association scan of suicidal thoughts and behaviour in major depressionAlexandra Schosser, Amy W Butler, Marcus Ising, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 26, 2014
Genetic relationships between suicide attempts, suicidal ideation and major psychiatric disorders: a genome-wide association and polygenic scoring studyNiamh Mullins, Nader Perroud, Rudolf Uher, et al.
The American Journal of Psychiatry|May 17, 2011
A genome-wide significant linkage for severe depression on chromosome 3: the depression network studyGerome Breen, Bradley Todd Webb, Amy W Butler, et al.
Journal of Medicinal Chemistry|September 21, 2011
Discovery of two clinical histamine H(3) receptor antagonists: trans-N-ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidinylmethyl)phenyl]cyclobutanecarboxamide (PF-03654746) and trans-3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]-N-(2-methylpropyl)cyclobutanecarboxamide (PF-03654764)Travis T Wager, Betty A Pettersen, Anne W Schmidt, et al.
The American Journal of Psychiatry|June 3, 2010
Genome-wide association study of major recurrent depression in the U.K. populationCathryn M Lewis, Mandy Y Ng, Amy W Butler, et al.
Pageof 35